These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 5727936)

  • 1. Prognosis in breast cancer on the basis of histological evaluation of malignancy according to the criteria of bloom.
    Dabska M
    Pol Med J; 1968; 7(4):908-16. PubMed ID: 5727936
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prognosis in mammary cancer on the basis of histological evaluation of malignancy according to Bloom's criteria].
    Dabska M
    Pol Tyg Lek; 1967 Oct; 22(43):1657-61. PubMed ID: 6064250
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prognostic value of breast cancer malignancy evaluation by the Bloom method in the records of the Surgical Institute of the Pomeranian Medical Academy in Szczecin].
    Chojnacki J
    Ann Acad Med Stetin; 1977; 23():333-50. PubMed ID: 606005
    [No Abstract]   [Full Text] [Related]  

  • 4. Histologic malignancy grading of the primary tumour as a prognostic factor in breast cancer.
    Nissen-Meyer R
    Scand J Clin Lab Invest Suppl; 1968; 106():181-4. PubMed ID: 5731704
    [No Abstract]   [Full Text] [Related]  

  • 5. An analytic critique of existing systems of staging for breast cancer.
    Charlson ME; Feinstein AR
    Surgery; 1973 Apr; 73(4):479-98. PubMed ID: 4690095
    [No Abstract]   [Full Text] [Related]  

  • 6. [Anatomo-pathological factors in breast cancer prognosis].
    Contesso G; Rouëssé J; Caen JL
    Ann Anat Pathol (Paris); 1973; 18(4):374-88. PubMed ID: 4793235
    [No Abstract]   [Full Text] [Related]  

  • 7. [TNM classification of breast cancer and prognosis].
    Kuno K
    Nihon Ishikai Zasshi; 1971 Jun; 65(12):1517-20. PubMed ID: 5104689
    [No Abstract]   [Full Text] [Related]  

  • 8. [Breast cancer from the viewpoint of the pathologist].
    Reiner A
    Wien Med Wochenschr; 2000; 150(4):58-62. PubMed ID: 10829305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Histological and other factors in the prognosis of cancer of the breast. Histological type of breast cancer and prognosis].
    Tomić S; Vukcević S; Vidović Z
    Med Arh; 1972; 26(3):3-13. PubMed ID: 5078126
    [No Abstract]   [Full Text] [Related]  

  • 10. [Sexchromatin findings and the clinical course of breast carcinoma].
    Descoeudres C
    Helv Chir Acta; 1968 Nov; 35(5):497-514. PubMed ID: 5710287
    [No Abstract]   [Full Text] [Related]  

  • 11. [Biological and clinical evaluation of 114 cases of cancer of the breast].
    Badellino F; Canavese G; Margarino G; Percivale PL; Cafiero F; Catturich A; Moresco L; Scala M; Amoretti G; Battistini G
    Minerva Ginecol; 1984 Oct; 36(10):587-92. PubMed ID: 6527810
    [No Abstract]   [Full Text] [Related]  

  • 12. [Usefulness of cytoprognostic classification combined with histoprognostic classification in breast cancer].
    Seigneurin D; Louis J; Seigneurin D
    Bull Assoc Anat (Nancy); 1993 Sep; 77(238):33-6. PubMed ID: 8148524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bilateral synchronous breast cancer. A clinical dilemma.
    Guraya SY; Khairy GA
    Saudi Med J; 2004 Dec; 25(12):2024-5. PubMed ID: 15711694
    [No Abstract]   [Full Text] [Related]  

  • 14. [Histological characteristics and prognosis of breast cancer, with special reference to correlation between histological type and stromal reaction and prognosis].
    Kobori O; Kusama S; Tomiyama J; Muto T; Kino I
    Gan No Rinsho; 1970; 16(3):223-7. PubMed ID: 5463018
    [No Abstract]   [Full Text] [Related]  

  • 15. [Histological and other factors in the prognosis of breast cancer--X. Clinical staging and prognosis].
    Tomić S; Skrkar M; Softić D; Kovacević N; Vukcević S
    Med Arh; 1974; 28(2):177-83. PubMed ID: 4846811
    [No Abstract]   [Full Text] [Related]  

  • 16. Tumor emboli in intramammary lymphatics in breast carcinoma: pathologic criteria for diagnosis and clinical significance.
    Rosen PP
    Pathol Annu; 1983; 18 Pt 2():215-32. PubMed ID: 6674861
    [No Abstract]   [Full Text] [Related]  

  • 17. [Breast cancer].
    Van Bogaert LJ
    Rev Fr Gynecol Obstet; 1984 May; 79(5):361-98. PubMed ID: 6098952
    [No Abstract]   [Full Text] [Related]  

  • 18. [Breast cancer].
    Ataseven B; Eiermann W
    Dtsch Med Wochenschr; 2006 May; 131(19):1091-9; quiz 1101-2. PubMed ID: 16685631
    [No Abstract]   [Full Text] [Related]  

  • 19. BRCA1. A new marker in the management of patients with breast cancer?
    Offit K
    Cancer; 1996 Feb; 77(4):599-601. PubMed ID: 8616748
    [No Abstract]   [Full Text] [Related]  

  • 20. High local recurrence risk is not associated with large survival reduction after postmastectomy radiotherapy in high-risk breast cancer: a subgroup analysis of DBCG 82 b&c.
    Kyndi M; Overgaard M; Nielsen HM; Sørensen FB; Knudsen H; Overgaard J
    Radiother Oncol; 2009 Jan; 90(1):74-9. PubMed ID: 18471914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.